Will Stone
-
Psychedelics could transform mental health care, but some advocates and researchers say there needs to be more focus on the minority of people with persistent troubles after using these drugs.
-
Depression affects about 300 million people worldwide. New research suggests a large share of people have a type of depression tied to disruptions in their circadian rhythms.
-
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
-
Psychological factors are critical in bouncing back from a sports injury. Researchers find that many people cleared to play don't actually return to sports.
-
Leading researchers in heat exposure are coming together to reach a consensus on what we know — and don't — about the health benefits of sauna and its potential for treating and preventing disease.
-
While scientists have a decent understanding of how sauna and other forms of heat exposure exercises our cardiovascular system, they know relatively little about its impact on mental health.
-
A reporting trip to a sauna conference in Oslo found NPR's Will Stone in a sauna with his clothes and recording gear. In this reporter's notebook, he explains how he investigates the science behind wellness claims.
-
The Trump administration has signaled it's behind the psychedelic renaissance, but there are still big questions about how these drugs will be administered once they are approved by the FDA.
-
Copper peptides are among the biggest viral trends on social media. Does evidence support smearing on the electric blue tincture for firmer skin, wound healing and other anti-aging effects?
-
The peptide is supposed to deliver flawless and firm skin, promote wound healing and other anti-aging effects. So what's the evidence behind GHK-Cu?